Biopharmaceutical company MindMed has announced the first topline data from a novel Phase 2 trial testing high doses of LSD as a treatment for anxiety. The results indicate one to two LSD sessions can ...

A Phase II clinical trial investigating the efficacy of the psychedelic compound lysergic acid diethylamide (LSD) in combination with psychotherapy for the treatment of anxiety has reported positive ...

Holding company Blackhawk Growth Corp.BLRZF's subsidiary company MindBio Therapeutics Pty Ltd shared the positive data gathered from its Phase 1 clinical trials microdosing LSD formulation in 80 ...

An incredible, first-of-its-kind trial testing the pain-killing properties of LSD microdoses has delivered the compelling suggestion that tiny, non-psychedelic doses of this infamous drug could serve ...

LSD has shown promise for treating conditions like depression, but it might not do much for ADHD. © cybermagician via Shutterstock LSD can do a lot of things, but ...

The magical and potent hallucinogen lysergic acid diethylamide (LSD) may have a new, clinically significant medical benefit: getting sleep. A new study, entitled “LSD Increases Sleep Duration the ...

Lysergic acid diethylamide, better known as LSD or acid, has a checkered past — or, perhaps, a roiling and vibrantly colored past. Since the drug was synthesized by chemist Albert Hoffman in 1938, ...

Low-dose treatment with lysergic acid diethylamide (LSD) failed to improve symptoms of attention deficit-hyperactivity ...

In this randomized study, microdosing LSD was not more effective than placebo in reducing ADHD symptoms in adults. Repeated doses of the low-dose LSD were safe in an outpatient setting.